Intrathecal pain management with ziconotide: Time for consensus?

Intrathecal pain management with ziconotide: Time for consensus?

Abstract This article summarizes recommendations made by six pain specialists who discussed the rationale for ziconotide intrathecal analgesia (ITA) and the requirement for evidence‐based guidance on its use, from a European perspective. Riemser Pharma GmbH (Greifswald, Germany), which holds the Eur...

Full description

Bibliographic Details
Main Authors: Georgios Matis, Pasquale De Negri, Denis Dupoiron, Rudolf Likar, Xander Zuidema, Dirk Rasche
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Brain and Behavior
Subjects:
cancer pain
chronic pain
consensus
intrathecal therapy
pain management
ziconotide
Online Access:https://doi.org/10.1002/brb3.2055

Internet

https://doi.org/10.1002/brb3.2055

Similar Items